NRC-07

General Information


DRACP ID  DRACP00323

Peptide Name   NRC-07

Sequence  RWGKWFKKATHVGKHVGKAALTAYL

Sequence Length  25

UniProt ID  Not available

PubChem CID  Not available

Origin  Pleurocidin-family

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia 50% Cell death=16 µg/ml MTT assay 2h 1

Hemolytic Activity  25 μM NRC-07: HMECs Cytotoxicity=20%, Fibroblasts Cytotoxicity=1%, HUVECs Cytotoxicity=17%; 50 μM NRC-07: HMECs Cytotoxicity=47%, Fibroblasts Cytotoxicity=0%, HUVECs Cytotoxicity=17%

Normal (non-cancerous) Cytotoxicity  Erythrocytes(25 μM NRC-07): Hemolysis=2%; Erythrocytes(50 μM NRC-07): Hemolysis=3%;

Target  Cell surface molecules

Affinity  Not available

Mechanism  NRC-03- and NRC-07-mediated cell death is initiated by peptide binding to negatively-charged molecules

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00323

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Biotinylated

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C136H209N39O29

Absent amino acids  CDEIMNPQS

Common amino acids  K

Mass  328268

Pl  11.39

Basic residues  8

Acidic residues  0

Hydrophobic residues  11

Net charge  8

Boman Index  -2165

Hydrophobicity  -40.4

Aliphatic Index  70.4

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  12490

Absorbance 280nm  520.42

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22023734

Title  Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts

Doi 10.1186/bcr3043

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.